TC BioPharm Holdings PLC (TCBP) Financials

$0.49

$-0.01 (-2.04%)

As on 17-Apr-2025 09:30EDT

Market cap

$0 Mln

Revenue (TTM)

$-- Mln

P/E Ratio

--

P/B Ratio

0.1

Div. Yield

0 %

Annual
Quarterly

Income Statement (£ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	--	3.84	1.98	1.98	3.43	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	3.84	1.98	1.98	3.43	--
Operating Expenses	6.91	0.12	13.52	8.32	10.07	--
Operating Profit (EBIT)	-14.24	-12.08	-7.29	-6.89	-6.64	--
Other Income	--	--	--	--	--	--
Profit before Tax	-7.00	-3.03	-14.98	-6.63	-6.89	--
Provision for Tax	-1.09	1.72	1.41	1.17	0.83	--
Profit after Tax (Net Income)	-5.91	-1.31	-13.58	-5.46	-6.07	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	-1.39	-13.58	-5.46	-6.07	--

Liabilities (£ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	2.69	0.33	-16.56	-3.35	-2.54	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	1.50	1.80	4.00	6.43	8.79	--
Current Liabilities	4.75	9.16	20.58	4.19	3.88	--
Total Liabilities	8.93	11.29	8.02	7.27	10.14	--

Assets (£ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	3.23	3.84	4.17	5.05	5.92	--
Current Assets	5.70	7.45	3.86	2.22	4.22	--
Total Assets	8.93	11.29	8.02	7.27	10.14	--
Total Debt*	1.80	2.45	15.87	2.58	3.02	--
Net Current Assets	0.95	-1.72	-16.72	-1.97	0.34	--

Cashflow (£ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	-10.54	-15.29	-5.58	-3.43	-6.73	--
Cash Flow from Investing Activities	--	-0.31	-0.14	-0.20	-2.20	--
Cash from Financing Activities	8.52	18.65	6.53	3.43	3.27	--
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS (£)	-0.03	-0.75	-24.19	-0.49	--	--
Cash EPS (£)	-0.03	-0.20	-22.36	-0.39	--	--
Adjusted Book Value (£)	0.01	0.19	--	--	--	--
Dividend per Share (£)	--	--	--	--	--	--
Cash Flow per Share (£)	-0.06	-8.76	-9.94	-0.31	--	--
Free Cash Flow per Share (£)	-0.06	-8.90	-9.98	-0.31	--	--

Profitability Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	-162.55	-125.63	1,866.13	3,895.78	--	--
ROE (%)	-391.64	16.19	136.40	185.44	--	--
ROA (%)	-58.42	-13.60	-177.58	-62.71	--	--
EBIT Margin (%)	--	-314.32	-368.28	-310.37	-193.78	--
Net Margin (%)	--	-34.17	-686.12	-275.84	-177.07	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	-1.00	0.94	--	-0.42	--	--
EBIT Growth (%)	-17.84	-65.83	-18.66	7.52	--	--
Net Profit Growth (%)	-349.68	90.32	-148.74	10.05	--	--
EPS Growth (%)	0.96	0.97	-48.74	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Solvency Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	0.67	7.40	-0.96	-0.77	-1.19	--
Short term debt to equity ratio	0.11	2.96	-0.46	-0.13	-0.16	--
Current Ratio	1.20	0.81	0.19	0.53	1.09	--
Quick Ratio	1.46	1.01	0.26	0.83	1.84	--
Interest Coverage	-171.51	-1.79	-2.12	-21.03	-24.11	--

Operating Efficiency Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	46.91	74.69	62.58	3.14	--
Asset Turnover	--	0.40	0.26	0.23	--	--
Receivable days	--	155.86	250.70	124.24	11.48	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--